Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Madhukar Pai

Datos Biográficos

ID3581834
NOMBREMadhukar Pai
NOMBRESMadhukar
APELLIDOPai
FIRMAPAI M
AFILIACIONESMcGill University
ORCID0000-0003-3667-4536
VERIFICADOSí
TOTAL DE OBRAS88
TOTAL DE CITAS7
TOTAL COMO AUTOR51
TOTAL COMO EDITOR37
PRIMER AÑO DE PUBLICACIÓN2009
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H2
  • Delays in tuberculosis diagnosis and treatment in India

    Open Access•Mohammad Abdullah Heel Kafi, Poshan Thapa et al.•ARTICLE•PLOS Global Public Health•2026

    Tuberculosis (TB) care for people with TB in India are often fragmented, undermining timely diagnosis and treatment. Understanding patient journeys is critical to strengthening TB care delivery and advancing elimination goals. We conducted a cross-sectional study of 400 people with TB diagnosed between 2020–2022 in two Indian cities: Mumbai (n = 200) and Patna (n = 200). Using structured interviews, we assessed care-seeking behavior, delays to di…

  • Globalisation, rising authoritarianism, declining solidarity, and retreating multilateralism

    Open Access•Winfred Dotse‐Gborgbortsi, Madhukar Pai et al.•ARTICLE•PLOS Global Public Health•2026

  • Antibiotic dispensing practices and determinants among informal healthcare providers in low- and middle-income countries

    Open Access•Poshan Thapa, Meera Tandan et al.•ARTICLE•BMJ Global Health•2026

    INTRODUCTION: Antimicrobial stewardship efforts in low- and middle-income countries (LMICs) largely focus on qualified practitioners, yet informal healthcare providers (IPs) deliver much of the primary care. Although these providers frequently dispense antibiotics, their practices remain poorly documented and are not captured in existing surveillance systems. METHODS: Using the Joanna Briggs Institute methodology, this scoping review synthesised …

  • A methodological review of patient healthcare-seeking journeys from symptom onset to receipt of care

    Open Access•Charity Oga‐Omenka, Angelina Sassi et al.•ARTICLE•BMJ Global Health•2025

    BACKGROUND: For many diseases, early diagnosis and treatment are more cost-effective, reduce community spread of infectious diseases and result in better patient outcomes. However, healthcare-seeking and diagnoses for several diseases are unnecessarily delayed. For example, in 2022, 3 million and 5.6 million people living with tuberculosis (TB) and HIV, respectively, were undiagnosed. Many patients never access appropriate testing, remain undiagn…

  • Health and tuberculosis systems resilience, the role of the private sector and pandemic preparedness

    Open Access•Laura Jane Brubacher, Vijayashree Yellappa et al.•ARTICLE•BMJ Global Health•2025

    Introduction The COVID-19 pandemic was an unprecedented challenge to health systems worldwide and had a severe impact on tuberculosis (TB) case notifications and service delivery. India, Indonesia and Nigeria are high TB-burden countries where the majority of initial care-seeking happens in the private health sector. The objectives of this study were to (1) explore policy-makers’ perspectives on the impact of the COVID-19 pandemic on private sect…

  • Scanned

    Open Access•Juno Min, Jarred Halton et al.•ARTICLE•PLOS Global Public Health•2025

  • Fighting tuberculosis hand in hand

    Open Access•Nandini Venkatesan, Lena Faust et al.•ARTICLE•PLOS Global Public Health•2025

    Tuberculosis (TB) is an infectious disease closely intertwined with stigma, discrimination, and the social determinants of health. Communities of people affected by TB are experts in their care pathways, but the TB field continues to fall short of meaningfully engaging communities in TB research. This is a missed opportunity to improve the quality, relevance, person-centeredness, positive impact, and sustainability of TB research outputs. We ackn…

  • Distribution and transmission of M. tuberculosis in a high-HIV prevalence city in Malawi

    Open Access•Melanie H Chitwood, Elizabeth L Corbett et al.•ARTICLE•PLOS Global Public Health•2025

    Delays in identifying and treating individuals with infectious tuberculosis (TB) contribute to poor health outcomes and allow ongoing community transmission of M. tuberculosis ( Mtb ). Current recommendations for screening for tuberculosis specify community characteristics (e.g., areas with high local tuberculosis prevalence) that can be used to target screening within the general population. However, areas of higher tuberculosis burden are not n…

  • Can we unplug global health education from The Matrix

    Open Access•Shashika Bandara, Ananya Tina Banerjee et al.•ARTICLE•PLOS Global Public Health•2025

  • “You can’t see what you’ve never had to live”—Cultivating imagination and solution spaces in global health and development

    Open Access•Safieh Shah, Shruti Bora et al.•ARTICLE•PLOS Global Public Health•2025

  • Improving the efficiency of the regulatory approvals of HIV in vitro diagnostics in low- and middle-income countries

    Open Access•Tammy Steuerwald, Duncan Blair et al.•ARTICLE•PLOS Global Public Health•2025

    In vitro diagnostics (IVDs) play a pivotal role in healthcare for the prevention, diagnosis, and treatment of infectious diseases, especially during epidemic and pandemic outbreaks. Improving access to IVDs holds promise for better healthcare outcomes, particularly in resource-limited settings. However, challenges persist, such as regulatory disparities and financial constraints, hindering broad access to IVDs. To address these challenges, the In…

  • Provider perspectives on empirical antibiotic treatment for tuberculosis-like symptoms in South Africa’s private general practice sector

    Open Access•Jeremiah Chikovore, Jody Boffa et al.•ARTICLE•PLOS Global Public Health•2025

    While tuberculosis (TB) in South Africa is commonly treated in the public sector, some clients first seek care in the private sector. Research has demonstrated that private general practitioners (GPs) perform less well than do public sector care providers in TB testing and drug-dispensing practices. We aimed to describe GPs’ decision-making practices related to empiric antibiotic treatment when presented with symptoms that may be related to TB, t…

  • Individual journeys to tuberculosis care in Nigeria’s private sector during the Covid-19 pandemic

    Open Access•Charity Oga‐Omenka, Lauren Rosapep et al.•ARTICLE•BMJ Global Health•2024

    BACKGROUND: Pre-COVID-19, individuals with tuberculosis (TB) in Nigeria were often underdiagnosed and untreated. TB services were mostly in the public sector with only 15% of new cases in 2019 reported from the private sector. Reports highlighted challenges in accessing care in the private sector, which accounted for 67% of all initial care-seeking. Our study examined patients' health seeking pathways for TB in Nigeria's private sector and explor…

  • Private sector tuberculosis care quality during the Covid-19 pandemic

    Open Access•Angelina Sassi, Lauren Rosapep et al.•ARTICLE•BMJ Global Health•2024

    Only a third of tuberculosis (TB) cases in Nigeria in 2020 were diagnosed and notified, in part due to low detection and under-reporting from the private health sector. Using a standardised patient (SP) survey approach, we assessed how management of presumptive TB in the private sector aligns with national guidelines and whether this differed from a study conducted before the start of the COVID-19 pandemic. 13 SPs presented a presumptive TB case …

  • Unlocking the potential of informal healthcare providers in tuberculosis care

    Open Access•Poshan Thapa, Padmanesan Narasimhan et al.•ARTICLE•BMJ Global Health•2024

    In 2022, tuberculosis (TB) remained a major global health concern, second only to COVID-19 in mortality from a single infectious agent

  • Community-friendly diagnostics

    Open Access•Fifa A Rahman, Kenly Sikwese et al.•ARTICLE•PLOS Global Public Health•2024

  • From lemming to leader

    Open Access•Tiffany Nassiri-Ansari, Nina Schwalbe et al.•ARTICLE•PLOS Global Public Health•2024

    Nearly 90 years after Simon Kuznets first introduced Gross Domestic Product (GDP) for the limited purpose of measuring economic growth (by measuring the monetary value of all local goods and services within a given period of time), calls continue to mount for decision-makers to stop using GDP and its derivate, Gross National Income (GNI), for purposes far beyond their original design [1].This is particularly true in the case of the development as…

  • Navigating time equity

    Open Access•Sharifah Sekalala, Shajoe Lake et al.•ARTICLE•PLOS Global Public Health•2024

    Since the start of the COVID-19 pandemic, there have been a surge in calls for equity to protect the world from future crises. Calls have emphasized equitable distribution of vaccines, a fair access and benefit sharing (ABS) system, and health systems strengthening, all leading to negotiation of a Pandemic Treaty

  • Conflicts in Gaza and around the world create a perfect storm for infectious disease outbreaks

    Open Access•John E Kearney, Natalie Thiel et al.•ARTICLE•PLOS Global Public Health•2024

    The global history of conflicts has revealed that infectious diseases resulting from displacement, overcrowding, healthcare collapse, destruction of critical water and sanitation infrastructure, and malnutrition can cause death rates equal or beyond those from direct violence The crisis in Gaza is no exception and has created a perfect storm for infectious disease outbreaks

  • The role of epistemic trust and epistemic disruption in vaccine hesitancy, conspiracy thinking and the capacity to identify fake news

    Open Access•Michal Tanzer, S S Settineri et al.•ARTICLE•PLOS Global Public Health•2024

    Epistemic trust ‐ defined as readiness to regard knowledge, communicated by another agent, as significant, relevant to the self, and generalizable to other contexts–has recently been applied to the field of developmental psychopathology as a potential risk factor for psychopathology. The work described here sought to investigate how the vulnerability engendered by disruptions in epistemic trust may not only impact psychological resilience and int…

  • Case fatality among people with drug-susceptible TB enrolled in a private health sector TB treatment support program in Bihar, India during the first year of the Covid-19 pandemic

    Open Access•Lena Faust, Ayushi Ranjan et al.•ARTICLE•PLOS Global Public Health•2024

    Experiencing 27% of the global tuberculosis (TB) burden, India’s TB epidemic is the largest in the world. Due to COVID-19-related disruptions to TB programs, India has also seen the largest drop in TB case notifications of any country globally. We estimated case fatality among people treated for TB in India during the pandemic and compared these to pre-pandemic estimates. A random sample of 4,000 adults enrolled in World Health Partners (WHP), a …

  • Drivers of success in global health outcomes

    Open Access•Nadia Akseer, David E Phillips et al.•ARTICLE•PLOS Global Public Health•2024

    Applying a positive outlier lens is one effective approach for generating evidence to inform global health policy, program, and funding decisions. Exemplars in Global Health (EGH) is a program that studies positive outlier countries that have made extraordinary progress in health outcomes (despite limited resources) and disseminates their successes through multiple types of outputs. To date, EGH has studied, or is studying, 14 global health topic…

  • The shifting landscape of private healthcare providers before and during the Covid-19 pandemic

    Open Access•Rodiah Widarna, Nur Afifah et al.•ARTICLE•PLOS Global Public Health•2024

    Introduction COVID-19 pandemic changed many aspects of healthcare services and deliveries, including among private healthcare providers (i.e., private healthcare facilities [HCFs] and private practitioners [PPs]). We aimed to compare the spatial distribution of private providers and describe changes in characteristics and services offered during and before the COVID-19 pandemic, and explore the tuberculosis (TB) and COVID-19-related services offe…

  • Potential implications of the climate crisis on diagnostics

    Open Access•Bernard Owusu Agyare, Paul Eder et al.•ARTICLE•PLOS Global Public Health•2024

  • From barrier to enabler

    Open Access•Marie Roseline Darnycka Bélizaire, Lynka Ineza et al.•ARTICLE•PLOS Global Public Health•2024

    Why language

Siguiente
  • Simulated patients and their reality

    Open Access•Veena Das, Benjamin Daniels et al.•ARTICLE•Social Science & Medicine•2022•Citada por: 4•Referencias: 26

    Simulated standardized patients (SSP) have emerged as close to a 'gold standard' for measuring the quality of clinical care. This method resolves problems of patient mix across healthcare providers and allows care to be benchmarked against preexisting standards. Nevertheless, SSPs are not real patients. How, then, should data from SSPs be considered relative to clinical observations with 'real' patients in a given health system? Here, we reject t…

  • Tuberculosis in times of Covid-19

    Open Access•Alexandra Jaye Zimmer, Joel Shyam Klinton et al.•ARTICLE•Journal of Epidemiology and…•2022•Citada por: 2•Referencias: 38

    The COVID-19 pandemic has caused widespread disruptions to tuberculosis (TB) care and service delivery in 2020, setting back progress in the fight against TB by several years. As newer COVID-19 variants continue to devastate many low and middle-income countries in 2021, the extent of this setback is likely to increase. Despite these challenges, the TB community can draw on the comprehensive approaches used to manage COVID-19 to help restore progr…

  • One Million Lives Saved Per Year

    Open Access•Carel Pretorius, Nimalan Arinaminpathy et al.•ARTICLE•Journal of Benefit-Cost Analysis•2023•Citada por: 1•Referencias: 1

    This report presents a cost–benefit analysis of increased spending on tuberculosis (TB) using impacts and costs drawn from the Global Plan to End Tuberculosis, 2023–2030. The analysis indicates that the return on TB spending is substantial with a centrally estimated benefit–cost ratio (BCR) of 46, meaning every US$ 1 invested in TB yields US$ 46 in benefits. Alternative specifications using different baselines, interventions, cost profiles, and d…

  • Profile of adults seeking voluntary HIV testing and counseling in rural Central India

    Nitika Pant Pai, Rajnish Joshi et al.•ARTICLE•AIDS Care•2009

    Rural India has an undetected load of HIV-positive individuals. Few rural adults present for HIV testing and counseling due to stigma, discrimination, and fear of social ostracization. In this rural hospital clinic-based study, we document profiles of rural adults seeking voluntary testing and counseling, and analyze correlates of HIV seropositivity. This cross-sectional study was conducted in 450 participants presenting to the outpatient clinics…

  • Diagnosing at Point of Care in South India

    Open Access•Nora Engel, Vijayashree Yellappa et al.•ARTICLE•Science & Technology Studies•2017

    Point-of-care testing promises to cut diagnostic and treatment delays by ensuring patients receive a management decision based on a diagnostic test within one encounter with a provider. Adding to STS work on diagnostics and the sociology of diagnosis, this paper examines the work involved in enacting point-of-care testing, how technology features and the embedded assumptions regarding patients. Using focus group discussions with providers and pat…

  • How patients navigate the diagnostic ecosystem in a fragmented health system

    Open Access•Vijayashree Yellapa, Narayanan Devadasan et al.•ARTICLE•Global Health Action•2017

    BACKGROUND: Depending on a country's diagnostic infrastructure, patients and providers play different roles in ensuring that correct and timely diagnosis is made. However, little is known about the work done by patients in accessing diagnostic services and completing the 'test and treat' loop. OBJECTIVE: To address this knowledge gap, we traced the diagnostic journeys of patients with tuberculosis, diabetes, hypertension and typhoid, and examined…

  • Will global health survive its decolonisation?

    Open Access•Seye Abimbola, Madhukar Pai•ARTICLE•The Lancet•2020

  • Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries

    Open Access•Anita Svadzian, Giorgia Sulis et al.•ARTICLE•BMJ Global Health•2020

  • Global health degrees

    Open Access•Anita Svadzian, Nathaly Aguilera Vasquez et al.•ARTICLE•BMJ Global Health•2020

    Allopolyploidization is a biological process that has played a major role in plant speciation and evolution. Genomic changes are common consequences of polyploidization, but their dynamics over time are still poorly understood. Coffea arabica, a recently formed allotetraploid, was chosen to study genetic changes that accompany allopolyploid formation. Both RNA-seq and DNA-seq data were generated from two genetically distant C. arabica accessions.…

  • Finding the missing millions

    Open Access•Tripti Pande, Nathaly Aguilera Vasquez et al.•ARTICLE•BMJ Global Health•2020

    box In 2019, 10.0 million people developed tuberculosis (TB) yet 2.9 million were not notified to National TB programmes (NTPs).1 This is largely due to limited accessibility to healthcare services, underdeveloped health reporting systems, insufficient human resources and poor linkages between private providers and national authorities.2 There are various global initiatives to address this challenge, including the Find.Treat.All #EndTB initiative…

  • Missing men with tuberculosis

    Open Access•Jeremiah Chikovore, Madhukar Pai et al.•ARTICLE•BMJ Global Health•2020

    Tuberculosis (TB) is treatable but is the leading infectious cause of death worldwide, with men over-represented in some key aspects of the disease burden. Men’s TB epidemiological scenario occurs within a wider public health and historical context, including their prior sidelining in health discussions. Differences are however noticeable in how some Western countries and high TB and HIV burden low and middle-income countries (LMIC) including in …

  • Tuberculosis case fatality in India

    Open Access•Sophie Huddart, Anita Svadzian et al.•ARTICLE•BMJ Global Health•2020

  • India’s syndemic of tuberculosis and Covid-19

    Open Access•Rukmini Shrinivasan, Saurabh Rane et al.•ARTICLE•BMJ Global Health•2020

    Chromatin instability and loss of protein homeostasis (proteostasis) are two well-established hallmarks of aging, which have been considered largely independent of each other. Using microfluidics and single-cell imaging approaches, we observed that, during the replicative aging of S.cerevisiae , proteostasis decline occurred specifically in the fraction of cells with decreased stability at the ribosomal DNA (rDNA) region. A screen of 170 yeast RN…

  • Antibiotic overuse in the primary health care setting

    Open Access•Giorgia Sulis, Benjamin Daniels et al.•ARTICLE•BMJ Global Health•2020

    INTRODUCTION: Determining whether antibiotic prescriptions are inappropriate requires knowledge of patients' underlying conditions. In low-income and middle-income countries (LMICs), where misdiagnoses are frequent, this is challenging. Additionally, such details are often unavailable for prescription audits. Recent studies using standardised patients (SPs) offer a unique opportunity to generate unbiased prevalence estimates of antibiotic overuse…

  • Addressing power asymmetries in global health

    Open Access•Seye Abimbola, Sumegha Asthana et al.•ARTICLE•PLoS Medicine•2021

    The Coronavirus Disease 2019 (COVID-19AU : PleasenotethatCOVID 19hasbeendefinedasCoro ) pandemic, the Black Lives Matter and Women in Global Health movements, and ongoing calls to decolonise global health have all created space for uncomfortable but important conversations that reveal serious asymmetries of power and privilege that permeate all aspects of global health.

  • Using the Covid-19 pandemic to reimagine global health teaching in high-income countries

    Open Access•Salla Atkins, Ananya Banerjee et al.•ARTICLE•BMJ Global Health•2021

  • Quality of care for tuberculosis and HIV in the private health sector

    Open Access•Jody Boffa, Sizulu Moyo et al.•ARTICLE•BMJ Global Health•2021

    BACKGROUND: South Africa has high burdens of tuberculosis (TB) and TB-HIV, yet the quality of patient care in the private sector is unknown. We describe quality of TB and TB-HIV care among private general practitioners (GPs) in two South African cities using standardised patients (SPs). METHODS: Sixteen SPs presented one of three cases during unannounced visits to private GPs in selected high-TB burden communities in Durban and Cape Town: case 1,…

  • PLOS Global Public Health, charting a new path towards equity, diversity and inclusion in global health

    Open Access•Catherine Kyobutungi, Julia Robinson et al.•ARTICLE•PLOS Global Public Health•2021

  • Engaging pharmacies in tuberculosis control

    Open Access•Jacob Bigio, Nathaly Aquilera Vasquez et al.•ARTICLE•BMJ Global Health•2022

  • Prescribing practices for presumptive TB among private general practitioners in South Africa

    Open Access•Angela Salomon, Jody Boffa et al.•ARTICLE•BMJ Global Health•2022

    INTRODUCTION: Medicine prescribing practices are integral to quality of care for leading infectious diseases such as tuberculosis (TB). We describe prescribing practices in South Africa's private health sector, where an estimated third of people with TB symptoms first seek care. METHODS: Sixteen standardised patients (SPs) presented one of three cases during unannounced visits to private general practitioners (GPs) in Durban and Cape Town: TB sym…

  • How we classify countries and people—and why it matters

    Open Access•Themrise Khan, Seye Abimbola et al.•ARTICLE•BMJ Global Health•2022

  • Tuberculosis diagnosis and management in the public versus private sector

    Open Access•Benjamin Daniels, Daksha Shah et al.•ARTICLE•BMJ Global Health•2022

    BACKGROUND: There are few rigorous studies comparing quality of tuberculosis (TB) care in public versus private sectors. METHODS: We used standardised patients (SPs) to measure technical quality and patient experience in a sample of private and public facilities in Mumbai. RESULTS: SPs presented a 'classic, suspected TB' scenario and a 'recurrence or drug-resistance' scenario. In the private sector, SPs completed 643 interactions. In the public s…

  • Global health education in high-income countries

    Open Access•Hoda Sayegh, Hoda E Sayegh et al.•ARTICLE•BMJ Global Health•2022

    Contemporary global health education is overwhelmingly skewed towards high-income countries (HICs). HIC-based global health curricula largely ignore colonial origins of global health to the detriment of all stakeholders, including trainees and affected community members of low- and middle-income countries. Using the Consortium of Universities for Global Health’s Global Health Education Competencies Tool-Kit , we analyse the current structure and …

  • Tracking changes in national BCG vaccination policies and practices using the BCG World Atlas

    Open Access•Samantha Lancione, Jonathan Villa Alvarez et al.•ARTICLE•BMJ Global Health•2022

    The BCG vaccine is a widely given vaccine against tuberculosis (TB), yet studies on effectiveness have shown considerable heterogeneity; as a result, BCG vaccine policies vary greatly across the globe and change across geography, and with time and disease burden. The recently updated third BCG World Atlas ( www.bcgatlas.org ) is a publicly available online database with information on BCG practices across 194 countries. This helpful resource has …

  • Most common reasons for primary care visits in low- and middle-income countries

    Open Access•Jacob Bigio, Emily Lai-Ho MacLean et al.•ARTICLE•PLOS Global Public Health•2022

    With the Covid-19 pandemic and the introduction of the WHO’s Essential Diagnostics List (EDL), increasing global attention is focused on the crucial role of diagnostics in achieving universal health coverage. To create national EDLs and to aid health system planning, it is vital to understand the most common conditions with which people present at primary care health facilities. We undertook a systematic review of the most common reasons for prim…

  • The great Texas Covid tragedy

    Open Access•Peter J Hotez, Madhukar Pai•ARTICLE•PLOS Global Public Health•2022

    The United States of America leads all high-income nations in COVID-19 deaths, even though as a nation at had the greatest access to antiviral vaccines and therapeutics. To understand this disconnect we can look to the COVID-19 deaths and disability in the State of Texas. Because of COVID-19, Texas is enduring one of the greatest human tragedies in its 186-year history. It did not have to be this way

  • Lifesaving, cost-saving

    Open Access•Aashta Gupta, Sandeep Juneja et al.•ARTICLE•PLOS Global Public Health•2022

    Aastha Gupta is a consultant to the Global Alliance for TB Drug Development (TB Alliance), a non-profit organization dedicated to the discovery and development of improved TB therapeutics

  • When it comes to stopping tuberculosis, what is actually “missing”

    Open Access•Farahdiba Zalika Fatah, Jennifer Furin et al.•ARTICLE•PLOS Global Public Health•2022

Medicine (60 obras) · Political science (29 obras) · Health care (27 obras) · Nursing (27 obras) · Tuberculosis Research and Epidemiology (24 obras) · Environmental health (23 obras) · Economic growth (22 obras) · Tuberculosis (22 obras) · Business (20 obras) · Family medicine (18 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae